Osteogenic efficiency of in situ gelling poloxamine systems with and without bone morphogenetic protein-2

European Cells and Materials

Volumn 21, Issue , 2011, Pages 317-340

  Rey Rico, Ana ^a   Silva, Maite ^a   Couceiro, José ^a   Concheiro, Angel ^a   Alvarez Lorenzo, Carmen ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

BMP 2; Bone regeneration; Controlled release; In situ gelling; Injectable hydrogel; Osteogenic induction; PEO PPO block copolymers; Poloxamine; Scaffold

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; COLLAGEN TYPE 1; COPOLYMER; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; POLOXAMER; POLOXAMINE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; TETRONIC 1107; TETRONIC 1301; TETRONIC 1307; TETRONIC 908; TETRONIC ACID DERIVATIVE; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; ETHYLENEDIAMINE DERIVATIVE; MACROGOL DERIVATIVE; SURFACTANT; TETRONIC 701;

ADIPOCYTE; ANIMAL CELL; ARTICLE; BONE MINERALIZATION; BONE REGENERATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMICAL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG FORMULATION; ENZYME ACTIVITY; EXCIPIENT COMPATIBILITY; FLOW KINETICS; GELATION; HISTOCHEMISTRY; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSTEOBLAST; PHASE TRANSITION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; TEMPERATURE; VISCOELASTICITY; ANIMAL; BONE DEVELOPMENT; CELL CULTURE; CELL STRAIN 3T3; CELL SURVIVAL; CHEMISTRY; CHO CELL; CRICETULUS; CYTOLOGY; DRUG EFFECT; GEL; GENE EXPRESSION; GENETICS; HAMSTER; METABOLISM; TUMOR CELL LINE;

ADIPOCYTES; ALKALINE PHOSPHATASE; ANIMALS; BALB 3T3 CELLS; BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CHO CELLS; COLLAGEN TYPE I; CORE BINDING FACTOR ALPHA 1 SUBUNIT; CRICETINAE; CRICETULUS; ETHYLENEDIAMINES; GELS; GENE EXPRESSION; HUMANS; MESENCHYMAL STEM CELLS; MICE; OSTEOBLASTS; OSTEOGENESIS; POLYETHYLENE GLYCOLS; SURFACE-ACTIVE AGENTS;

EID: 79960974092     PISSN: 14732262     EISSN: None     Source Type: Journal    
DOI: 10.22203/eCM.v021a24     Document Type: Article

References (81)

1. Al-Hanbali O, Onwuzo NM, Rutt KJ, Dadswell CM, Moghimi SM, Hunter AC (2007) Modification of the Stewart biphasic colorimetric assay for stable and accurate quantitatitive determination of Pluronic and Tetronic block copolymers for application in biological systems. Analytical Biochem. 361: 287-293.
2. Alvarez-Lorenzo C, Rey-Rico A, Brea J, Loza MI, Concheiro A, Sosnik A (2010a) Inhibition of P-glycoprotein pumps by PEO-PPO amphiphiles: Linear versus branched derivatives. Nanomedicine UK 5: 1371-1383.
3. Alvarez-Lorenzo C, Rey-Rico A, Sosnik A, Taboada P, Concheiro A (2010b) Poloxaminebased nanomaterials for drug delivery. Front Biosci E2: 424-440.
4. Alvarez-Lorenzo C, Gonzalez-Lopez J, Fernandez-Tarrio M, Sandez-Macho I, Concheiro A (2007) Tetronic micellization, gelation and drug solubilization: influence of pH and ionic strength. Eur J Pharm Biopharm 66: 244-252.
5. Anderson BC, Pandit NK, Mallapragada SK (2001) Understanding drug release from poly(ethylene oxide)- b-poly(propylene oxide)-b-poly(ethylene oxide) gels. J Control Release 70: 157-167.
6. Bessa PC, Casal M, Reis RL (2008a) Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts). J Tissue Eng Regen Med 2: 1-13.
7. Bessa PC, Casal M, Reis RL (2008b) Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Regen Med 2: 81-96.
8. Bishop GB, Einhorn TA (2007) Current and future clinical applications of bone morphogenetic proteins in orthopaedic trauma surgery. Int Orthop 31: 221-226.
9. Bromberg LE, Ron ES (1998) Temperature-responsive gels and thermogelling polymers matrices for protein and peptide delivery. Adv Drug Del Revs 31: 197-221.
10. Chaibundit C, Ricardo NMPS, Costa FMLL, Yeates SG, Booth C (2007) Micellization and gelation of mixed copolymers P123 and F127 in aqueous solution. Langmuir 23: 9229-9236.
11. Cheng H, Jiang W, Phillips FM, Haydon RC, Peng Y, Zhou L, Luu HH, An N, Breyer B, Vanichakarn P, Szatkowski JP, Park JY, He TC (2003) Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 85: 1544-1552.
12. Chiappetta DA, Sosnik A (2007). Poly (ethylene oxide)- poly (propylene oxide) block copolymer micelles as drug delivery agents: Improved hydrosolubility, stability and bioavailability of drugs. Eur J Pharm Biopharm 66: 303-331.
13. Chiappetta DA, Alvarez-Lorenzo C, Rey-Rico A, Taboada P, Concheiro A, Sosnik A (2010) N-alkylation of poloxamines modulates micellar assembly and encapsulation and release of the antiretroviral efavirenz. Eur J Pharm Biopharm 76: 24-37.
14. Clokie CM, Urist MR (2000) Bone morphogenetic protein excipients: comparative observations on poloxamer. Plast Reconstr Surg 105: 628-637.
15. Cosmetic Ingredient Review (CIR) Expert Panel (2008) Safety assessment of poloxamers 101, 105, 108, 122, 123, 124, 181, 182, 183, 184, 185, 188, 212, 215, 217, 231, 234, 235, 237, 238, 282, 284, 288, 331, 333, 334, 335, 338, 401, 402, 403, and 407, poloxamer 105 benzoate, and poloxamer 182 dibenzoate as used in cosmetics. Int J Toxicol 27: 93-128.
16. Cowan CM, Aalami OO, Shi YY, Chou YF, Mari C, Thomas R, Quarto N, Nacamuli RP, Contag CH, Wu B, Longaker MT (2005) Bone morphogenetic protein 2 and retinoic acid accelerate in vivo bone formation, osteoclast recruitment, and bone turnover. Tissue Eng 11: 645-658.
17. Date T, Doiguchi Y, Nobuta M, Shindo H (2004) Bone morphogenetic protein-2 induces differentiation of multipotent C3H10T1/2 cells into osteoblasts, chondrocytes, and adipocytes in vivo and in vitro. J Orthop Sci 9: 503-508.
18. Exner AA, Krupka TM, Scherrer K, Teets JM (2005) Enhancement of carboplatin toxicity by Pluronic block copolymers. J Control Release 106: 188-197.
19. Fisher JP, Jo S, Mikos AG, Reddi AH (2004) Thermoreversible hydrogel scaffolds for articular cartilage engineering. J Biomed Mater Res Part A 71A: 268-274.
20. Geiger M, Li RH, Friess W (2003) Collagen sponges for bone regeneration with rhBMP-2. Adv Drug Deliver Rev 55: 1613-1629.
21. Gonzalez-Lopez J, Alvarez-Lorenzo C, Taboada P, Sosnik A, Sandez-Macho I, Concheiro A (2008) Self- associative behavior and drug-solubilizing ability of poloxamine (tetronic) block copolymers. Langmuir 24: 10688-10697
22. Gonzalez-Lopez J, Sandez-Macho I, Concheiro A, Alvarez-Lorenzo C (2010) Poloxamines and poloxamers as polymeric micellar carriers for simvastatin: interactions at the air-water interface and in bulk solution. J Phys Chem C 114: 1181-1189.
23. Harris MT, Butler DL, Boivin GP, Florer JB, Schantz EJ, Wenstrup RJ (2004) Mesenchymal stem cells used for rabbit tendon repair can form ectopic bone and express alkaline phosphatase activity in constructs. J Orthop Res 22: 998-1003.
24. He C, Kim SW, Lee DS (2008) In situ gelling stimulisensitive block copolymer hydrogels for drug delivery. J Control Release 127: 189-207.
25. Hedoux WJF, Paccou L, Guinet Y, Affouard F, Lerbret A, Descamps M (2009) Thermostabilization mechanism of bovine serum albumin by trehalose. J Phys Chem B 113: 6119-6126.
26. Helder MN, Wuisman PIJM, Zandieh Doulabi B (2007) Method for induction of differentiation of stem and progenitor cells. Patent WO/2007/108689.
27. Helm GA, Sheehan JM, Sheehan JP, Jane JA Jr, diPierro CG, Simmons NE, Gillies GT, Kallmes DF, Sweeney TM (1997) Utilization of type I collagen gel, demineralized bone matrix, and bone morphogenetic protein-2 to enhance autologous bone lumbar spinal fusion. J Neurourg 86: 93-100.
28. Hing KA (2004) Bone repair in the twenty-first century: biology, chemistry or engineering? Phil. Trans. R. Soc. Lond. A 362: 2821-2850.
29. Hsieh CY, Hsieh HJ, Liu HC, Wang DM, Hou LT (2006) Fabrication and release behavior of a novel freeze-gelled chitosan/g-PGA scaffold as a carrier for rhBMP-2. Dent Mater 22: 622-629.
30. Hutmacher DW, Sugunan SLC (2004) Bone repair and adult stem cells, in: Stem Cells, from Bench to Bedside, Bongso A, Lee EH (Eds), World Scientific Publishing Co., Singapore, p. 451.
31. Issa JPM, do Nascimento C, Iyomasa MM, Siessere S, Regalo SCH, Defino HLA, Sebald W (2008) Bone healing process in critical-sized defects by rhBMP-2 using poloxamer gel and collagen sponge as carriers. Micron 39: 17-24.
32. Itosaka H, Kuroda S, Shichinohe H, Yasuda H, Yano S, Kamei S, Kawamura R, Hida K, Iwasaki Y (2009) Fibrin matrix provides a suitable scaffold for bone marrow stromal cells transplanted into injured spinal cord: A novel material for CNS tissue engineering. Neuropathology 29: 248-257.
33. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP (1997) Osteogenic differentiation of purified, cultureexpanded human mesenchymal stem cells in vitro. J Cell Biochem 64: 295-312.
34. Jeon O, Song SJ, Kang S, Putnam AJ, Kim B (2007) Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparinconjugated poly(L-lactic-co-glycolic acid) scaffold. Biomaterials 28: 2763-2771.
35. Jeon JH, Puleo DA (2008) Alternating release of different bioactive molecules from a complexation polymer system. Biomaterials 29: 3591-3598
36. Ji XH, Chen D, Xu C, Harris SE, Mundy GR, Yoneda T (2000) Patterns of gene expression associated with BMP-2-induced osteoblast and adipocyte differentiation of mesenchymal progenitor cell 3T3-F442A. J Bone Miner Metab 18: 132-139.
37. Jones DS, Muldoon BCO, Woolfson AD, Andrews GP, Mccoy CP, Sanderson FD (2010) Moisture-activated rheological structuring of nonaqueous poloxaminepoly(acrylic acid) systems designed as novel biomedical implants. J Pharm Sci 99: 1838-1854.
38. Kabanov AV, Alakhov VY (2002) Pluronic(R) block copolymers in drug delivery: From micellar nanocontainers to biological response modifiers. Crit Rev Ther Drug 19: 1-72.
39. Kato S, Kawabata N, Suzuki N, Ohmura M, Takagi M (2009) Bone morphogenetic protein-2 induces the differentiation of a mesenchymal progenitor cell line, ROB-C26, into mature osteoblasts and adipocytes. Life Sci 84: 302-310.
40. Kim HD, Valentini RF (2002) Retention and activity of BMP-2 in hyaluronic acid-based scaffolds in vitro. J Biomed Mater Res 59: 573-584.
41. Kim HW, Lee HH, Chun GS (2008) Bioactivity and osteoblast responses of novel biomedical nanocomposites of bioactive glass nanofiber filled poly(lactic acid). J Biomed Mater Res 85A: 651-663.
42. Krupka TM, Dremann D, Exner AA (2009) Time and dose dependence of pluronic bioactivity in hyperthermiainduced tumor cell death. Exp Biol Med 234: 95-104.
43. Li RH, Wozney JM (2001) Delivering on the promise of bone morphogenetic proteins. Trends Biotechnol 19: 255-265.
44. Li X, Yao J, Wu L, Jing W, Tang W, Lin Y, Tian W, Liu L (2009) Osteogenic induction of adipose-derived stromal cells: not a requirement for bone formation in vivo. Artif Organs 34: 46-54.
45. Luginbuehl V, Meinel L, Merkle HP, Gander B (2004) Localized delivery of growth factors for bone repair. Eur J Pharm Biopharm 58: 197-208.
46. Lutolf MP, Lauer-Fields JL, Schmoekel HG, Metters AT, Weber FE, Fields GB, Hubbell JA (2003a) Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: Engineering cellinvasion characteristics. Proc Natl Acad Sci USA 100: 5413-5418.
47. Lutolf MP, Weber FE, Schmoekel HG, Schense JC, Kohler T, Mueller R, Hubbell JA (2003b) Repair of bone defects using synthetic mimetics of collagenous extracellular matrices. Nat Biotechnol 21: 513-518.
48. McKay WF, Peckham SM, Badura JM (2007) A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE Bone Graft). Int Orthop 31: 729-734.
49. Moghimi SM, Hunter AC, Murray JC (2001) Longcirculating and target-specific nanoparticles: theory to practice. Pharmacol Rev 53: 283-318.
50. Moses MA, Sudhalter J, Langer R (1992) Isolation and characterization of an inhibitor of neovascularization from scapular chondrocytes. J Cell Biol 119: 475-482.
51. Niemeyer P, Kasten P, Simank HG, Fellenberg J, Seckinger A, Kreuz PC, Mehlhorn A, Südkamp NP, Krause U (2006) Transplantation of mesenchymal stromal cells on mineralized collagen leads to ectopic matrix synthesis in vivo independently from prior in vitro differentiation. Cytotherapy 8: 354-366.
52. Park JC, Park BJ, Lee DH, Suh H, Kim D-G, Kwon O-H (2002) Evaluation of the citotoxicty of polyetherurethane (PU) film containing zinc diethyldithiocarbamate (ZDEC) on various cell lines. Yonsei Med J 43: 518-526.
53. Pelin IM, Maeir SS, Chitanu GC, Bulacovschi (2009) Preparation and characterization of a hydroxyapatitecollagen composite as component for injectable bone substitute. Mat Sci Eng C-Mater 29: 2188-2194.
54. Poynton AR, Lane JM (2002) Safety profile for the clinical use of bone morphogenetic proteins in the spine. Spine 27: 40-48.
55. Pratt AB, Weber FE, Schmoekel HG, Mueller R, Hubbell JA (2004) Synthetic extracellular matrixes for in situ tissue engineering. Biotechnol Bioeng 86: 27-36.
56. Puppi D, Chiellini F, Piras A M, Chiellini E (2010) Polymeric materials for bone and cartilage repair. Prog Polym Sci 35: 403-440.
57. Rai B, Teoh SH, Hutmacher DW, Cao T, Ho KH (2005) Novel PCL-based honeycomb scaffolds as drug delivery systems for rhBMP-2. Biomaterials 26: 3739-3748.
58. Reddi AH (2005) BMPs: from bone morphogenetic proteins to body morphogenetic proteins. Cytokine Growth F R 16: 249-250.
59. Schoichet MS (2010) Polymer scaffolds for biomedical applications. Macromolecules 43: 581-591.
60. Seeherman HJ, Bouxsein M, Kim H, Li R, Li XJ, Aiolova M, Wozney JM (2004) Recombinant human bone morphogenetic protein-2 delivered in an injectable calcium phosphate paste accelerates osteotomy-site healing in a nonhuman primate model. J Bone Joint Surg Am 86: 1961-1972.
61. Seeherman H, Wozney JM (2005) Delivery of bone morphogenetic proteins for orthopedic tissue regeneration. Citokyne Growth F R 16: 329-345.
62. Shen H, Hu X, Yang F, Bei J, Wang S (2009) The bioactivity of rhBMP-2 immobilized poly(lactide-coglycolide) scaffolds. Biomaterials 30: 3150-3157.
63. Sopyana I, Melb M, Ramesh S, Khalid KD (2007) Porous hydroxyapatite for artificial bone applications. Sci Technol Adv Mater 8: 116-123.
64. Sosnik A, Leung BM, Sefton MV (2008) Lactoylpoloxamine/collagen matrix for cell-containing tissue engineering modules. J Biomed Mat Res A 86A: 339-353.
65. Takahashi Y, Yamamoto M, Tabata Y (2005) Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and β-tricalcium phosphate. Biomaterials 26: 4856-4865.
66. Tjabringa GS, Zandieh-Doulabi B, Helder MN, Knippenberg M, Wuisman PIJM, Klein-Nulend J (2008) The polymine spermine regulates osteogenic differentiation in adipose stem cells. J Cel Mol Med 12: 1710-1717.
67. Trentz OA, Arikketh D, Sentilnathan V, Hemmi S, Handschin AE, de Rosario B, Mohandas P, Mohandas PVA (2010) Surface proteins and osteoblast markers: characterization of human adipose tissue-derived osteogenic cells. Eur J Trauma Emerg Surg 36: 457-463.
68. Uludag H, D'Augusta D, Plamer R, Timony G; Wozney J (1999) Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model. J. Biomed. Mater Res 46: 193-202.
69. Urist MR (1965) Bone: formation by autoinduction. Science 150: 893-898.
70. Vashi AV, Keramidaris E, Abberton KM, Morrison WA, Wilson JL, O'Connor AJ, Cooper-White JJ, Thompson EW (2008) Adipose differentiation of bone marrow-derived mesenchymal stem cells using Pluronic F-127 hydrogel in vitro. Biomaterials 29: 573-579.
71. Wahlstroem O, Linder C, Anders K, Per M (2007) Variation of pH in lysed platelet concentrates influence proliferation and alkaline phosphatase activity in human osteoblast-like cells. Platelets 18: 113-118.
72. Wang EA, Rosen V, D'Alessandro JS, Bauduy M, Cordes P, Harada T, Israel DI, Hewick RM, Kerns M, LaPan P (1990) Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 87: 2220-2224.
73. Westerhuis RJ, van Bezooijen RL, Kloen P (2005) Use of bone morphogenetic proteins in traumatology. Injury, Int J Care Injured 36: 1405-1412.
74. White AP, Vaccaro AR, Hall JA, Whang PG, Friel BC, McKee MD (2007) Clinical applications of BMP-7/OP-1 in fractures, nonunions and spinal fusion. Int Orthop 31: 735-741.
75. Winn SR, Uludag H, Hollinger JO (1999) Carrier systems for bone morphogenetic proteins. Clin Orthop 357: 95-106.
76. Woerle G, Siekmann B, Koch MHJ, Bunje H (2006) Transformation of vesicular into cubic nanoparticles by autoclaving of aqueous monoolein/poloxamer dispersions. Eur J Pharm Sci 27: 44-53.
77. Xian W (2009) A laboratory course in biomaterials. CRC Press, Boca Raton, p. 115.
78. Yang SH, Hsu CK, Wang KC, Hou SM, Lin FH (2005) Tricalcium phosphate and glutaraldehyde crosslinked gelatin incorporating bone morphogenetic protein - a viable scaffold for bone tissue engineering. J Biomed Mater Res B Appl Biomater 74: 468-475.
79. Yin Z, Chen X, Chen JL, Ouyang HW (2010) Stem cells for tendon tissue engineering and regeneration. Expert Opin Biol Ther 10: 1-12.
80. Yu L, Ding J (2008) Injectable hydrogels as unique biomedical materials. Chem Soc Rev 37: 1473-1481.
81. Zuk PA, Zhu M, Ashjian P, de Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH (2002) Human adipose tissue is a source of multipotent stem cells. Mol Cell Biol 13: 4279-4295.